References
- 1. Conte MS, Bradbury AW, Kolh P, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery. 2019;58:S1-S109.e33. doi: 10.1016/j.ejvs.20196.05.006.
- 2. Jamieson C. The definition of critical ischaemia of a limb. Br J Surg. 1982;69 Suppl:S1.10.1002/bjs.1800691118
- 3. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. Journal of Vascular Surgery. 1997;26:517-538. doi: 10.1016/S0741-5214(97)70045-4.
- 4. Abu Dabrh AM, Steffen MW, Asi N, et al. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. Journal of Vascular Surgery. 2016;63:244-253.e11. doi: 10.1016/j.jvs.2015.07.068.26372187
- 5. Niculescu R, Russu E, Arbănași EM, et al. Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. International Journal of Environmental Research and Public Health. 2022;19:13934. doi: 10.3390/ijerph192113934.965488836360814
- 6. Cosarca MC, Horváth E, Molnar C, Molnár GB, Russu E, Mureșan VA. Calcification patterns in femoral and carotid atheromatous plaques: A comparative morphometric study. Experimental and Therapeutic Medicine. 2021;22:1-9. doi: 10.3892/etm.2021.10297.822065034178138
- 7. Cosarca MC, Hălmaciu I, Muresan AV, et al. Neutrophil-to-lymphocyte, platelet-to-lymphocyte and lymphocyte-to-monocyte ratios are associated with amputation rates in patients with peripheral arterial disease and diabetes mellitus who underwent revascularization: A Romanian regional center study. Experimental and Therapeutic Medicine. 2022;24:1-8. doi: 10.3892/etm.2022.11639.962340436337294
- 8. Russu E, Mureșan AV, Arbănași EM, et al. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. Journal of Clinical Medicine. 2022;11:2620. doi: 10.3390/jcm11092620.910310435566745
- 9. Mureșan AV, Russu E, Arbănași EM, et al. The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients. Biomedicines. 2022;10:1272. doi: 10.3390/biomedicines10061272.922015935740294
- 10. Kaller R, Arbănași EM, Mureșan AV, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels’ Diameters in Arteriovenous Fistula Maturation Failure. Life. 2022;12:1447. doi: 10.3390/life12091447.950639536143483
- 11. Arbănași EM, Mureșan AV, Coșarcă CM, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Impact on Predicting Outcomes in Patients with Acute Limb Ischemia. Life. 2022;12:822. doi: 10.3390/life12060822.922556535743853
- 12. Melinte RM, Arbănași EM, Blesneac A, et al. Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty. Medicina. 2022;58:1502. doi: 10.3390/medicina58101502.960831036295662
- 13. Arbănași EM, Mureșan AV, Arbănași EM, et al. The Neutrophilto-Lymphocyte Ratio’s Predictive Utility in Acute Pulmonary Embolism: Systematic Review. Journal Of Cardiovascular Emergencies. 2022;8:25-30. doi: 10.2478/jce-2022-0005.
- 14. Vunvulea V, Budișcă OA, Arbănași EM, et al. The Predictive Role of Systemic Inflammatory Markers in the Development of Acute Kidney Failure and Mortality in Patients with Abdominal Trauma. Journal of Personalized Medicine. 2022;12:2045. doi: 10.3390/jpm12122045.978192736556265
- 15. Halmaciu I, Arbănași EM, Kaller R, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients’ Mortality. Diagnostics. 2022;12:2089. doi: 10.3390/diagnostics12092089.949750936140490
- 16. Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12:2757. doi: 10.3390/diagnostics12112757.968915036428817
- 17. Arbănași EM, Halmaciu I, Kaller R, et al. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics. 2022;12:2379. doi: 10.3390/diagnostics12102379960043436292068
- 18. Mureșan AV, Russu E, Arbănași EM, et al. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania. Journal of Clinical Medicine. 2022;11:2452. doi: 10.3390/jcm11092452.910427835566576
- 19. Emil-Marian A, Reka K, Vasile Adrian M, Septimiu V, Eliza-Mihaela A, Eliza R. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935.944581236081587
- 20. Varma V, Sinibaldi D, Ongstad EL, et al. Abstract 11971: Identification of Response Biomarkers and Signaling Pathways Associated With the LOX-1 Blockade by MEDI6570 in Type 2 Diabetes. Circulation. 2022;146(Suppl_1):A11971-A11971. doi: 10.1161/circ.146.suppl_1.11971.
- 21. Vlad ML, Mares RG, Lazar AG, et al. Monocyte-derived macrophages mediate S100a8/A9-induced oxidative stress and inflammation in the ischemic myocardium. Atherosclerosis. 2022;355:268. doi: 10.1016/j.atherosclerosis.2022.06.1008.
- 22. Zhang Z, Chen Z. Higher Systemic Immune-Inflammation Index is Associated With Higher Likelihood of Peripheral Arterial Disease. Annals of Vascular Surgery. 2022;84:322-326. doi: 10.1016/j.avsg.2021.12.011.34954036
- 23. Paquissi FC. The role of inflammation in cardiovascular diseases: the predictive value of neutrophil–lymphocyte ratio as a marker in peripheral arterial disease. Ther Clin Risk Manag. 2016;12:851-860. doi: 10.2147/TCRM.S107635.489283327313459
- 24. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-657. doi: 10.1016/j.amjcard.2008.05.006.18773982
- 25. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395:27-31. doi: 10.1016/j. cca.2008.04.019.
- 26. Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;110:621-627. doi: 10.1016/j.amjcard.2012.04.041.22608360
- 27. Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225:456-460. doi: 10.1016/j.atherosclerosis.2012.09.009.23040448
- 28. Azab B, Bhatt VR, Phookan J, et al. Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients. Ann Surg Oncol. 2012;19:217-224. doi: 10.1245/s10434-011-1814-0.21638095
- 29. Arbel Y, Shacham Y, Ziv-Baran T, et al. Higher neutrophil/lymphocyte ratio is related to lower ejection fraction and higher long-term all-cause mortality in ST-elevation myocardial infarction patients. Can J Cardiol. 2014;30(:1177-1182. doi: 10.1016/j.cjca.2014.05.010.25154806
- 30. Turak O, Ozcan F, Isleyen A, et al. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol. 2012;110:1405-1410. doi: 10.1016/j.amjcard.2012.07.003.22858185
- 31. Taşoğlu I, Turak O, Nazli Y, et al. Preoperative neutrophillymphocyte ratio and saphenous vein graft patency after coronary artery bypass grafting. Clin Appl Thromb Hemost. 2014;20:819-824. doi: 10.1177/1076029613484086.23580624
- 32. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007;154:995-1002. doi: 10.1016/j.ahj.2007.06.043.17967611
- 33. Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014;234:206-213. doi: 10.1016/j.atherosclerosis.2014.03.003.24681815
- 34. Tokgoz S, Keskin S, Kayrak M, Seyithanoglu A, Ogmegul A. Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume? J Stroke Cerebrovasc Dis. 2014;23:2163-2168. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.007.25106834
- 35. Wang F, Hu S, Ding Y, et al. Neutrophil-to-Lymphocyte Ratio and 30-Day Mortality in Patients with Acute Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2016;25:182-187. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.013.26500171
- 36. Brooks SD, Spears C, Cummings C, et al. Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg. 2014;6:578-583. doi: 10.1136/neurintsurg-2013-010780.437361824122003
- 37. Hyun S, Kwon S, Cho S, et al. Can the Neutrophil-to-Lymphocyte Ratio Appropriately Predict Carotid Artery Stenosis in Patients with Ischemic Stroke?-A Retrospective Study. J Stroke Cerebrovasc Dis. 2015;24:2646-2651. doi: 10.1016/j.jstrokecerebrovasdis.2015.07.024.26316355
- 38. Gökhan S, Ozhasenekler A, Mansur Durgun H, Akil E, Ustündag M, Orak M. Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci. 2013;17:653-657.
- 39. Belaj K, Pichler M, Hackl G, et al. Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia. Angiology. 2016;67(4):350-354. doi: 10.1177/0003319715590701.26058674
- 40. Gary T, Pichler M, Belaj K, et al. Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One. 2013;8:e56745. doi: 10.1371/journal.pone.0056745.357410323457609
- 41. Luo H, Yuan D, Yang H, et al. Post-treatment neutrophillymphocyte ratio independently predicts amputation in critical limb ischemia without operation. Clinics (Sao Paulo). 2015;70:273-277. doi: 10.6061/clinics/2015(04)09.441835526017794
- 42. Taşoğlu İ, Sert D, Colak N, Uzun A, Songur M, Ecevit A. Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost. 2014;20:645-650. doi: 10.1177/1076029613475474.23393289
- 43. Kullar P, Weerakoddy R, Walsh S. Neutrophil-Lymphocyte Ratio Predicts Graft Patency Following Lower Limb Revascularisation. Acta Chirurgica Belgica. 2012;112:365-368. doi: 10.1080/00015458.2012.11680853.23175925
- 44. Erturk M, Cakmak HA, Surgit O, et al. Predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol. 2014;64:371-376. doi: 10.1016/j.jjcc.2014.02.019.24685686
- 45. Spark JI, Sarveswaran J, Blest N, Charalabidis P, Asthana S. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. Journal of Vascular Surgery. 2010;52:632-636. doi: 10.1016/j.jvs.2010.03.067.20573475
- 46. Chan C, Puckridge P, Ullah S, Delaney C, Spark JI. Neutrophillymphocyte ratio as a prognostic marker of outcome in infrapopliteal percutaneous interventions for critical limb ischemia. Journal of Vascular Surgery. 2014;60:661-668. doi: 10.1016/j.jvs.2014.03.277.24816510
- 47. González-Fajardo JA, Brizuela-Sanz JA, Aguirre-Gervás B, et al. Prognostic Significance of an Elevated Neutrophil–Lymphocyte Ratio in the Amputation-free Survival of Patients with Chronic Critical Limb Ischemia. Annals of Vascular Surgery. 2014;28:999-1004. doi: 10.1016/j.avsg.2013.06.037.24559786
- 48. Bhutta H, Agha R, Wong J, Tang TY, Wilson YG, Walsh SR. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg. 2011;45:227-231. doi: 10.1177/1538574410396590.21289130
- 49. Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery. Cells. 2022;11:1124. doi: 10.3390/cells11071124.899759835406687
- 50. Lee S, Hoberstorfer T, Wadowski PP, Kopp CW, Panzer S, Gremmel T. Platelet-to-lymphocyte and Neutrophil-tolymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation. Journal of Clinical Medicine. 2020;9:1729. doi: 10.3390/jcm9061729.735594432503291
- 51. Teperman J, Carruthers D, Guo Y, et al. Relationship between neutrophil-lymphocyte ratio and severity of lower extremity peripheral artery disease. Int J Cardiol. 2017;228:201-204. doi: 10.1016/j.ijcard.2016.11.097.846416127865186